scholarly journals Malignant stromal cell tumor of the spleen in a WBN/Kob rat

Author(s):  
Yui TERAYAMA ◽  
Tetsuro MATSUURA ◽  
Kiyokazu OZAKI
Keyword(s):  
2009 ◽  
Vol 1 (1) ◽  
pp. 46-52 ◽  
Author(s):  
Alexander Rabinovich ◽  
Isabella W.Y. Mak ◽  
Robert W. Cowan ◽  
Robert E. Turcotte ◽  
Nigel Colterjohn ◽  
...  

2001 ◽  
Vol 32 (8) ◽  
pp. 796-802 ◽  
Author(s):  
Noriko Kato ◽  
Masayuki Fukase ◽  
Iwao Ono ◽  
Kazuhito Matsumoto ◽  
Etsuo Okazaki ◽  
...  

2007 ◽  
Vol 459 ◽  
pp. 8-13 ◽  
Author(s):  
Michelle Ghert ◽  
Nicole Simunovic ◽  
Robert W Cowan ◽  
Nigel Colterjohn ◽  
Gurmit Singh

2005 ◽  
Vol 23 (1) ◽  
pp. 203-209 ◽  
Author(s):  
Ted S. Liao ◽  
Matthew B. Yurgelun ◽  
Seong-Sil Chang ◽  
Hui-Zhu Zhang ◽  
Koko Murakami ◽  
...  

2006 ◽  
Vol 24 (8) ◽  
pp. 592-594
Author(s):  
Toshiko Yamano ◽  
Kumiko Ando ◽  
Reiichi Ishikura ◽  
Norio Nakao ◽  
Toshitada Ogasawara

2000 ◽  
Vol 179 (4) ◽  
pp. 252 ◽  
Author(s):  
Ann Neuhaus ◽  
Richard J Bold
Keyword(s):  

2018 ◽  
Vol 142 (10) ◽  
pp. 1289-1291 ◽  
Author(s):  
Ryan DeCoste ◽  
Saul L. Offman

Signet ring stromal cell tumor is a rare, benign ovarian neoplasm thought to arise from ovarian stromal cells. The pathophysiology of these tumors is poorly understood. They present in women in a wide age range, often with nonspecific symptoms including lower abdominal or pelvic pain. Their morphologic appearance raises a critical differential diagnosis of Krukenberg tumor, an aggressive malignancy with significant implications for patient management. For this reason, it is important for the pathologist to be aware of signet ring stromal cell tumor and its differentiating features, including useful histochemical and immunohistochemical ancillary tests. These tumors are curable with surgical excision, and there have been no recurrences or metastases among reported cases.


Sign in / Sign up

Export Citation Format

Share Document